Lynn M. Flickinger

Recruitment strategies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: The first six years

N. Simpson, Christine Cole Johnson, Sheryl Ogden et al. · Controlled Clinical Trials · 2000 · 58 citations

Medicine, Oncology, Urology +13

Design and evolution of the data management systems in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Marsha Hasson, Richard M. Fagerstrom, Dalia C. Kahane et al. · Controlled Clinical Trials · 2000 · 41 citations

Health Professions, Health Informatics, Oncology +11

Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence.

Marvella E. Ford, Suzanne Havstad, Lynn M. Flickinger et al. · PubMed · 2003 · 37 citations

Medicine, Oncology, Preventive Medicine +17

Mammographic Breast Density Response to Aromatase Inhibition

Celine M. Vachon, Vera J. Suman, Kathleen R. Brandt et al. · Clinical Cancer Research · 2013 · 33 citations · Full text

Medicine, Endocrinology, Oncology +15

Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance).

Paul Haluska, Albert M. Bernath, Karla V. Ballman et al. · Journal of Clinical Oncology · 2014 · 10 citations

Medicine, Oncology, Pharmacology +17